Long-term effects of smoking and smoking cessation on exercise stress testing: three-year outcomes from a randomized clinical trial.

[1]  Megan E. Piper,et al.  Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. , 2011, American heart journal.

[2]  L. Shaw,et al.  Heart Rate Response to Exercise Stress Testing in Asymptomatic Women: The St. James Women Take Heart Project , 2010, Circulation.

[3]  Megan E. Piper,et al.  Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. , 2010, Journal of the American College of Cardiology.

[4]  W. Kraus,et al.  Exercise, Abdominal Obesity, Skeletal Muscle, and Metabolic Risk: Evidence for a Dose Response , 2009, Obesity.

[5]  Megan E. Piper,et al.  Smoking intensity and lipoprotein abnormalities in active smokers. , 2009, Journal of clinical lipidology.

[6]  Megan E. Piper,et al.  A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. , 2009, Archives of general psychiatry.

[7]  B. Stamford,et al.  Smoking and smoking cessation -- the relationship between cardiovascular disease and lipoprotein metabolism: a review. , 2008, Atherosclerosis.

[8]  S. Munjal,et al.  Effects of Different Levels of Cigarette Smoke Exposure on Prognostic Heart Rate and Rate—Pressure-Product Parameters , 2008, Journal of cardiovascular pharmacology and therapeutics.

[9]  M. Irigoyen,et al.  Cardiovascular effects of smoking abstinence at rest and during submaximal exercise in young female smokers , 2008 .

[10]  Lucinar Jupir Forner Flores,et al.  Efeitos cardiovasculares da abstinência do fumo no repouso e durante o exercício submáximo em mulheres jovens fumantes , 2007 .

[11]  A. Evangelou,et al.  Effects of chronic smoking on exercise tolerance and on heart rate-systolic blood pressure product in young healthy adults , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[12]  Daniel Eisenberg,et al.  Estimating the effect of smoking cessation on weight gain: an instrumental variable approach. , 2006, Health services research.

[13]  Jason Gong,et al.  Efficacy of Varenicline, an 42 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation A Randomized Controlled Trial , 2006 .

[14]  David Gonzales,et al.  Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation: A Randomized Controlled Trial , 2006 .

[15]  Rainer Rauramaa,et al.  Heart rate response during exercise test and cardiovascular mortality in middle-aged men. , 2006, European heart journal.

[16]  S. Rennard,et al.  Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. , 2006, JAMA.

[17]  N. Rigotti,et al.  Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. , 2006, JAMA.

[18]  R. McKelvie,et al.  Metabolic profile and exercise capacity outcomes: their relationship to overweight and obesity in a Canadian cardiac rehabilitation setting. , 2004, Journal of cardiopulmonary rehabilitation.

[19]  Daniel S Berman,et al.  The incremental prognostic value of percentage of heart rate reserve achieved over myocardial perfusion single-photon emission computed tomography in the prediction of cardiac death and all-cause mortality: superiority over 85% of maximal age-predicted heart rate. , 2004, Journal of the American College of Cardiology.

[20]  Richard Doll,et al.  Mortality in relation to smoking: 22 years' observations on female British doctors. , 1980, British medical journal.

[21]  J. Ambrose,et al.  The pathophysiology of cigarette smoking and cardiovascular disease: an update. , 2004, Journal of the American College of Cardiology.

[22]  B. Ainsworth,et al.  International physical activity questionnaire: 12-country reliability and validity. , 2003, Medicine and science in sports and exercise.

[23]  N. Benowitz.  Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. , 2003, Progress in cardiovascular diseases.

[24]  G. Hunter,et al.  Muscle metabolic function, exercise performance, and weight gain. , 2003, Medicine and science in sports and exercise.

[25]  J. Twisk,et al.  A longitudinal study on smoking in relationship to fitness and heart rate response. , 2003, Medicine and science in sports and exercise.

[26]  Victor F. Froelicher,et al.  Exercise capacity and mortality among men referred for exercise testing. , 2002, The New England journal of medicine.

[27]  V F Froelicher,et al.  Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. , 2001, Circulation.

[28]  D. Hedeker,et al.  Statistical analysis of randomized trials in tobacco treatment: longitudinal designs with dichotomous outcome. , 2001, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[29]  V. Froelicher,et al.  Diagnostic exercise tests on 4000 consecutive men. , 2001, American heart journal.

[30]  K. Kawahara,et al.  Effects of abstinence from cigarette smoking on the cardiorespiratory capacity. , 2000, Medicine and science in sports and exercise.

[31]  M. Lauer,et al.  Heart-rate recovery immediately after exercise as a predictor of mortality. , 1999, The New England journal of medicine.

[32]  A. Maggioni,et al.  Prognostic significance of double product and inadequate double product response to maximal symptom-limited exercise stress testing after myocardial infarction in 6296 patients treated with thrombolytic agents. GISSI-2 Investigators. Grupo Italiano per lo Studio della Sopravvivenza nell-Infarto Mioc , 1999, American heart journal.

[33]  N. Benowitz,et al.  Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. , 1997, Journal of the American College of Cardiology.

[34]  K. Flegal,et al.  Exposure of the US population to environmental tobacco smoke: the Third National Health and Nutrition Examination Survey, 1988 to 1991. , 1996, JAMA.

[35]  K. Flegal,et al.  The influence of smoking cessation on the prevalence of overweight in the United States. , 1995, The New England journal of medicine.

[36]  L. Sandvik,et al.  Long term effects of smoking on physical fitness and lung function: a longitudinal study of 1393 middle aged Norwegian men for seven years , 1995, BMJ.

[37]  P. Thompson,et al.  ACSM's Guidelines for Exercise Testing and Prescription , 1995 .

[38]  L. Andersen,et al.  Coronary heart disease risk factors, physical activity, and fitness in young Danes. , 1995, Medicine and science in sports and exercise.

[39]  J. Gardin,et al.  Cigarette smoking and submaximal exercise test duration in a biracial population of young adults: the CARDIA study. , 1993, Medicine and science in sports and exercise.

[40]  R B D'Agostino,et al.  The health risks of smoking. The Framingham Study: 34 years of follow-up. , 1993, Annals of epidemiology.

[41]  J. E. Hansen,et al.  Immediate effects of cigarette smoking on cardiorespiratory responses to exercise. , 1985, Journal of applied physiology.

[42]  B BALKE,et al.  An experimental study of physical fitness of Air Force personnel. , 1959, United States Armed Forces medical journal.